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Gas exchange in COVID-19 pneumonia is impaired and vessel obstruction has been sus-
pected to cause ventilation-perfusion mismatch. Dual-energy CT (DECT) can depict pulmo-
nary perfusion by regional assessment of iodine uptake.
Objective
The purpose of this study was the analysis of pulmonary perfusion using dual-energy CT in
a cohort of 27 consecutive patients with severe COVID-19 pneumonia.
Method
We retrospectively analyzed pulmonary perfusion with DECT in 27 consecutive patients
(mean age 57 years, range 21–73; 19 men and 8 women) with severe COVID-19 pneumo-
nia. Iodine uptake (IU) in regions-of-interest placed into normally aerated lung, ground-glass
opacifications (GGO) and consolidations was measured using a dedicated postprocessing
software. Vessel enlargement (VE) within opacifications and presence of pulmonary embo-
lism (PE) was assessed by subjective analysis. Linear mixed models were used for statisti-
cal analyses.
Results
Compared to normally aerated lung 106/151 (70.2%) opacifications without upstream PE
demonstrated an increased IU, 9/151 (6.0%) an equal IU and 36/151 (23.8%) a decreased
IU. The estimated mean iodine uptake (EMIU) in opacifications without upstream PE (GGO
1.77 mg/mL; 95%-CI: 1.52–2.02; p = 0.011, consolidations 1.82 mg/mL; 95%-CI: 1.56–2.08,
p = 0.006) was significantly higher compared to normal lung (1.22 mg/mL; 95%-CI: 0.95–1.49).
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In case of upstream PE, EMIU of opacifications (combined GGO and consolidations) was sig-
nificantly decreased compared to normal lung (0.52 mg/mL; 95%-CI: -0.07–1.12; p = 0.043).
The presence of VE in opacifications correlated significantly with iodine uptake (p<0.001).
Conclusions
DECT revealed the opacifications in a subset of patients with severe COVID-19 pneumonia
to be perfused non-uniformly with some being hypo- and others being hyperperfused. Mean
iodine uptake in opacifications (both ground-glass and consolidation) was higher compared
to normally aerated lung except for areas with upstream pulmonary embolism. Vessel
enlargement correlated with iodine uptake: In summary, in a cohort of 27 consecutive
patients with severe COVID-19 pneumonia, dual-energy CT demonstrated a wide range of
iodine uptake in pulmonary ground-glass opacifications and consolidations as a surrogate
marker for hypo- and hyperperfusion compared to normally aerated lung. Applying DECT to
determine which pathophysiology is predominant might help to tailor therapy to the individ-
ual patient´s needs.
Introduction
Oxygenation of patients suffering from COVID-19 pneumonia is reported to be difficult due
to a ventilation-perfusion mismatch [1–4]. Over the course of the SARS-CoV-2 pandemic
we had to learn that COVID-19 is associated with a high risk of thrombotic and embolic
events notably in the second, hyperinflammatory stage of disease [5–12]. Autopsy studies
showed endothelial injury and widespread thrombosis with microangiopathy [13, 14].
Thus, ventilation-perfusion mismatch is thought to be mainly due to dead space ventilation.
Therefore, aggressive anticoagulation is meanwhile accepted part of therapy [15]. Somewhat
contradictory to the outlined pathophysiology is the fact that vessel enlargement within pul-
monary opacifications is a frequent finding on CT indicating rather hyperaemia than vessel
occlusion [16–18]. Ventilation-perfusion mismatch might therefore also be caused by shunt-
ing [1, 3].
Dual-energy computed tomography (DECT) pulmonary angiography is an established tool
to assess the regional distribution of pulmonary perfusion [19–21]. Several groups applied
DECT to analyze pulmonary perfusion patterns in COVID-19 pneumonia [22–26]. The results
are inhomogeneous. Si-Mohamed et al. found lobes with predominant GGO (early phase of
disease) to be hyperperfused and lobes with predominant consolidation (late phase of disease)
to be hypoperfused [22]. On the contrary, Ridge saw a decreasing amount of perfusion defects
after day 14 [23]. Grillet et al. reported hyperperfusion of both ground glass opacities (GGO)
and consolidation [24]. Lang et al. reported about a mixture of hypo- and hyperperfused opaci-
fications [26]. The latter two groups did not provide any data about the phase of disease. Dif-
ferent disease phases, extremely inhomogeneous patient groups with different portions of
mildly and severely diseased patients, different modes of analysis (subjective versus objective)
and missing correlation with upstream pulmonary embolism might be the reasons for the con-
flicting results.
The purpose of this study was the objective analysis of pulmonary perfusion using DECT in
a cohort of 27 consecutive patients with severe COVID-19 pneumonia including correlation
with vessel enlargement and pulmonary embolism.
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Materials and methods
From April 1st, 2020 all CTs of the chest in patients with severe COVID-19 pneumonia (dys-
pnea, respiratory frequency� 30/min, blood oxygen saturation� 93%, partial pressure of
arterial oxygen to fraction of inspired oxygen ratio < 300, and / or lung infiltrates > 50%
within 24 to 48 hours) [27] were performed contrast-enhanced using dual-energy mode.
These prospectively acquired data were retrospectively evaluated. The study was approved by
the institutional ethics committee (ethics committee of the Regensburg University Medical
Center, IRB nr. 20-1784-104). Written informed consent was waived. All procedures per-
formed in studies involving human participants were in accordance with the ethical standards
of the institutional and / or national research committee and with the 1964 Helsinki declara-
tion and its later amendments or comparable ethical standards.
Study population
The inclusion criteria were consecutive adult patients (� 18 years old) with RT-PCR-proven
SARS-CoV-2 infection and COVID-19 pneumonia who had a contrast-enhanced DECT of the
chest performed between April 1st and May15th 2020 at our university tertiary care medical
center. Image quality of all examinations was rated before analysis. Exclusion criteria were
non-diagnostic CTs due to technical artifacts. In case of more than one CT per patient, the
first CT only was analyzed. Patients were identified by means of a full-text database query of
all CT-scans performed between April 1st and May 15th 2020 using the term “�COVID�” OR
�SARS� in the Radiological Information System (RIS, Nexus.med RIS, Version 8.42, Nexus,
Villingen-Schwenningen, Germany) and by searching the electronic patients records for
SARS-CoV-2 RT-PCR results. Patient characteristics (age, gender, date of symptom onset,
referring ward and ventilation and / or ECMO status) and anticoagulation and corticosteroid
therapy status at the time of the dual-energy CT were extracted from electronic patient rec-
ords. CT imaging parameters including contrast medium injection modus were extracted
from the DICOM protocols of the scans.
CT protocol
All patients underwent contrast-enhanced DECT of the chest with or without additional scans
of the head and / or abdomen. All DECT examinations were performed in supine position
during end-inspiratory hold using a second generation dual-source CT scanner (Siemens
Somatom Definition Flash; Siemens Healthcare, Erlangen, Germany). The contrast medium
was iohexol (Accupaque 350, GE Healthcare Buchler, Braunschweig, Germany) administered
at a flow rate of 3–5 mL/s. 70 mL were injected for examinations of the chest only. 100 mL
were injected for chest examinations in combination with other body regions. The scan was
triggered with a bolus-tracking technique. For this, a region of interest (ROI) was placed into
the main pulmonary artery. The scan started with a scan delay of 5 seconds after reaching a
threshold of 100 Hounsfield Units (HU). All DECT were performed with 100 kVp (tube A)
and 140 kVp with tin filter (tube B) with a quality reference mA setting of 150 mA (for tube A)
using the combined angular and longitudinal automatic tube current modulation technique
(CARE Dose 4D, Siemens Healthcare, Erlangen, Germany).
Image postprocessing
From each DECT data set perfusion images were calculated using a dedicated dual-energy
postprocessing software for assessment of pulmonary perfused blood volume (PBV) (syngo.
CT Dual Energy, version VB30A, Siemens Healthcare, Erlangen, Germany). The preset
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parameters for tissue recognition were minimum -960 HU and maximum -600 HU. These val-
ues are the default setting for evaluation of normally aerated lung and do not allow for analysis
of opacified lung. Thus, the maximum was manually set to +150 HU to also include ground
glass opacities and consolidation into the analysis. Normalization was performed by placing a
dedicated ROI into the main pulmonary artery. Perfusion images were reconstructed as maxi-
mum intensity projections (MIP) in three planes (axial, coronal, sagittal) with a slice thickness
of 5 mm and an increment of 5 mm. For colour-coding the look-up table (LUT) overlay „Spec-
trum 10”was applied. Distribution of colours were set in such a way that another colour was
displayed for an enhancement increase of 8 HU each. Moreover, multiplanar reconstructions
(MPR) applying lung (B60f) and soft-tissue (I31f/2) kernel were generated from weighted aver-
age images (60% from the 140 kVp and 40% from the 100 kVp data). MPRs were reconstructed
in three planes (axial, coronal, sagittal) with a slice thickness of 1 mm and an increment of 0.75
mm. The images were sent to a picture archiving and communication system (PACS, Syngo
Imaging, Siemens Healthcare, Erlangen, Germany).
Image analysis
In a first step, overall image quality considering motion and beam hardening artifacts, con-
trast-noise ratio and opacification of pulmonary arteries of all dual-energy CT examinations
meeting the inclusion criteria was subjectively assessed by two readers in consensus: one
board-certified general radiologist with 12 years of experience (JR) and one subspeciality
thoracic radiologist with 15 years of experience (FP), using a four-point scale: 1, excellent, no
artifacts; 2, good, mild impairment of image quality without impairment of evaluability; 3, sat-
isfactory, moderate impairment of image quality without impairment of evaluability; and 4,
inadequate, severe artifacts, not evaluable for pulmonary perfusion analysis. Dual-energy
image analysis was performed in consensus by a subspecialty thoracic radiologist with 15 years
of experience (FP) and a board-certified general radiologist with 12 years of experience (JR).
Both readers were blinded to clinical patient status. Colour-coded pulmonary perfused blood
volume (PBV) images were displayed side by side with MPR in lung and soft-tissue window.
The colour-coded PBV maps were displayed as axial maximum intensity projections at 5 milli-
meters reconstruction slice thickness. MPRs were analyzed regarding the presence and distri-
bution of GGO and consolidation. The ROIs for consolidation and GGO were drawn as large
as possible. Mixed areas were intentionally excluded in order to collect data purely represent-
ing consolidation and GGO, respectively. Pulmonary embolism (PE) was recorded. The diam-
eter of vessels within opacifications was evaluated. Vessel enlargement was defined as clearly
larger vessel diameter compared to vessels of the same generation in normally aerated lung tis-
sue. Also, pulmonary embolism (PE) upstream of opacification was recorded.
Iodine uptake (mg/mL lung tissue) was measured 1. by placing a ROI in normally aerated
lung, 2. by placing a ROI in each of up to three separate areas of GGO and 3. by placing a ROI
in each of up to three separate areas of consolidation. The decision which areas of GGO and
consolidation were analyzed was made according to the colour-coded PBV map. Opacifica-
tions with least, medium and most intense enhancement were selected in order to record the
entire range of perfusion of GGO and consolidation, respectively.
Statistical analysis
Categorical data are presented as absolute and relative frequencies, while continuous data are
presented using mean, standard deviation (SD) and range (min-max). Differences in the
iodine uptake between normally aerated lung and opacified lung (separated into GGO and
consolidation), between vessel enlargement and no vessel enlargement, and between iodine
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uptake downstream to pulmonary embolism and no pulmonary embolism, were analyzed by
using linear mixed models. To account for repeated measurements of patients within the GGO
and consolidation areas, patients nested within the respective area were added as a random
factor to the models. Estimated means and corresponding 95%-confidence intervals are pre-
sented as effect estimates. A p-value<0.05 was considered statistically significant for all analy-
ses. All analyses were performed by using SAS (Version 9.4, The SAS institute, Cary, NC) and
the procedure proc mixed.
Results
Patient population
29 patients were eligible. The CTs of 2 patients were excluded due to severe technical artifacts
(classified as score of 4 in overall image quality assessment, see below). Thus 27 patients (19
men (70%) and 8 women (30%)) were included in the study. Mean age was 57 years (SD 13
years, range 21–73 years). The mean interval from symptom onset to the date of the DECT was
23.4 days (SD 12.8 days; range: 7–62 days). At the time of DECT, 26 patients (96%) were treated
on the intensive care unit, and one patient (4%) was treated on the general ward. 24 patients
(89%) were mechanically ventilated, and 9 patients (33.3%) were on extracorporeal membrane
oxygenation. The clinical indication for DECT was critical worsening of symptoms in 25
patients (92.6%) and suspicion of pulmonary embolism in 5 patients (18.5%). At the time of
DECT, all 27 patients had at least prophylactic anticoagulation therapy, with 16 patients (59.3%)
receiving full-dose therapeutic anticoagulation and 2 patients (7.4%) receiving half-therapeutic
dose anticoagulation. At the time of DECT, 8 patients (29.6%) received corticosteroid therapy.
20 DECT examinations were combined scans of several body regions (head, abdomen). 7 scans
were chest examinations only. Patient demographics are summarized in Table 1.
Image analysis
Overall image quality of the evaluated dual-energy CTs was excellent (score of 1) in 7 cases
(24.1%), good (score of 2) in 16 cases (55.2%), satisfactory (score of 3) in 4 cases (13.8%) and inad-
equate (score of 4) in 2 cases (6.9%). The two cases with score 4 were excluded from analysis. The
estimated mean iodine uptake of normally aerated lung was 1.22 mg/mL (95%-CI 0.95, 1.49).
Three different areas of GGO could be analyzed in all 27 scans, resulting in 81 measurements. As
for consolidation, three measurements could be made in 25 scans and two measurements in 2
scans, resulting in 79 measurements (Table 2). Fig 1 illustrates the range of iodine uptake of both
GGO and consolidation displayed as difference to normally aerated lung for each scan.
Pulmonary perfused blood volume (PBV) without upstream pulmonary embolism.
There was a considerable inhomogeneity of iodine density in opacifications even when focus-
ing on opacifications without upstream PE (Table 3). The estimated mean iodine uptake for
GGO and consolidation without evidence of upstream PE was higher than that in normally
Table 1. Patient demographics.
Patient demographics
Age (years), mean (SD, range) 57 (13, 21–73)
Gender 19 m (70%), 8 w (30%)
Days from symptom onset to date of DECT, mean (SD, range) 23.4 (12.8, 7–62)
Patients on intensive care unit 26 (96%)
Patients mechanically ventilated 24 (89%)
Patients on general ward 1 (4%)
https://doi.org/10.1371/journal.pone.0252478.t001
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aerated lung: GGO 1.77 mg/mL (95%-CI: 1.52–2.02), consolidation: 1.82 mg/mL (95%-
CI:1.56–2.08) (shown in Figs 2–5). The difference of the estimated mean iodine uptake values
of normally aerated and opacified lung was significant for both GGO (p = 0.011) and consoli-
dation (p = 0.006). In contrast, no significant difference was seen regarding the iodine uptake
of ground glass and consolidation (p = 0.791).
PBV without upstream pulmonary embolism and vessel enlargement. Vessel enlarge-
ment (VE) was present in 57/79 (72.2%) of GGO areas and in 41/72 (56.9%) of consolidated
areas without upstream PE. When VE was present without upstream PE, GGO was hyperper-
fused in 50/57 (87.7%) and equally or hypoperfused compared to normally aerated lung in
4/57 (7%) and 3/57 (5.3%), respectively. When VE was present, consolidation was hyperper-
fused in 36/41 (87.8%) and equally or hypoperfused compared to normally aerated lung in
1/41 (2.4%) and 4/41 (9.8%), respectively. Estimated mean iodine uptake of areas of GGO
demonstrating VE was 2.01 mg/mL (95%-CI: 1.74–2.28) and estimated mean iodine uptake of
areas of consolidation with accompanying VE was 2.28 mg/mL (95%-CI: 1.98–2.57). Without
accompanying VE, the estimated mean iodine uptake of areas of GGO and of consolidation
was 1.15 mg/mL (95%-CI: 0.79–1.50) and 1.21 mg/mL (95%-CI: 0.9–1.53). Statistical analysis
showed that the estimated mean iodine uptake of opacified lung areas (GGO and consolida-
tion) with VE was significantly higher as compared to estimated mean iodine uptake of areas
Fig 1. a. Difference of maximum and minimum of iodine uptake (mg/mL; x-axis) in ground-glass opacification
compared to normally aerated lung. Each horizontal line represents one patient (y-axis; order of patients from top to
bottom as in Table 2). b. Difference of maximum and minimum of iodine uptake (mg/mL; x-axis) in consolidation
compared to normally aerated lung. Each horizontal line represents one patient (y-axis; order of patients from top to
bottom as in Table 2).
https://doi.org/10.1371/journal.pone.0252478.g001












increased 60 52 2 48 36 0
equally 5 4 0 4 1 0
decreased 16 3 0 27 6 7
total 81 59 2 79 43 7
� Relative to iodine uptake in normally aerated lung.
https://doi.org/10.1371/journal.pone.0252478.t003
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of GGO and consolidation with normal vessel width (p<0.001) (shown in Fig 6). The esti-
mated mean iodine uptake of opacified lung areas (GGO and consolidation) without VE did
not differ from that of normally aerated lung.
PBV with upstream pulmonary embolism. PE upstream to the measurement ROI was
present in 2/81 (2.5%) of GGO and in 7/79 (8.9%) of consolidated areas. The estimated mean
iodine uptake of areas with GGO and consolidation (combined) without and with evidence of
upstream PE was 1.79 mg/mL (95%-CI: 1.62–1.97) and 0.52 mg/mL (95%-CI: -0.07–1.12),
respectively. The difference was significant (p<0.001).
Fig 2. Iodine uptake in normally aerated lung and ground-glass opacifications (two different patients, a) and b). Ground-glass
opacifications demonstrated a higher iodine density as compared to normally aerated lung.
https://doi.org/10.1371/journal.pone.0252478.g002
Fig 3. Iodine uptake in normally aerated lung and consolidation. Three reconstructions of the identical slice position, a. MPR in lung window, b. colour-coded
PBV MIP with thresholds for tissue recognition set to minimum -100 HU and maximum + 150 HU for visualization of iodine density in consolidation and c.
colour-coded PBV MIP with thresholds for tissue recognition set to minimum -960 HU and maximum -600 HU for visualisation of iodine density in normally
aerated lung. Parameter settings were separated for this illustration only in order to enable a clear depiction of perfusion differences by optimizing the range of
the look-up table to tissue density. Consolidations (arrows) demonstrated a higher iodine density as compared to normally aerated lung (see colour-coding scale).
https://doi.org/10.1371/journal.pone.0252478.g003
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Discussion
Since December 2019 the world suffers from the new Coronavirus SARS-CoV 2 induced air-
way disease. Despite extensive scientific work-up the pathophysiology of lung injury caused by
COVID-19 pneumonia is subject of ongoing controversy [1–4]. The discussion is mainly
driven by the observation of an unusual ventilation pattern in terms of a combination of
preserved lung compliance with severely impaired gas exchange. It was hypothesized that
SARS-CoV 2 infection leads to significant vascular obstruction due to pulmonary embolism
and / or in-situ thrombosis [28]. The resulting dead-space ventilation could explain the
observed hypoxaemia. Meanwhile this hypothesis has been supported by autopsy results in
several case series showing extensive microthrombi [13, 14]. However, an alternative explana-
tion for hypoxaemia is significant shunting. Vessel enlargement is frequently observed within
the opacified lung parenchyma of patients with COVID-19 pneumonia [16–18]. This feature
seems to be unique for SARS-CoV 2 and has not been shown for other types of pneumonia.
Several study groups evaluated lung perfusion based on the analysis of DECT data [22–26, 29].
Fig 4. Iodine uptake in normally aerated lung and opacifications with and without upstream pulmonary embolism. Four
reconstructions of the identical slice position, a. MPR in lung window, b. MPR in soft tissue window, c. colour-coded PBV MIP with
thresholds for tissue recognition set to minimum -960 HU and maximum -400 HU for visualisation of iodine density in normally
aerated lung and GGO and d. colour-coded PBV MIP with thresholds for tissue recognition set to minimum -100 HU and maximum
+150 HU for visualization of iodine density in consolidation. Parameter settings were separated for this illustration only in order to
enable a clear depiction of perfusion differences by optimizing the range of the look-up table to tissue density. Extensive diffuse GGO
is present. Several consolidations are seen in the posterior segments of both lower lobes. Subsegmental pulmonary embolism is
identified in the right lower lobe (arrowhead). Iodine density of lung tissue downstream of PE (bold arrows) is decreased while iodine
uptake in GGO and in particular in consolidations (thin arrows) without upstream PE is increased compared to normally aerated lung
(see colour- coding scale).
https://doi.org/10.1371/journal.pone.0252478.g004
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The results are inconsistent probably due to different study setups and even more so inhomo-
geneous study populations and disease stages. However, meanwhile it is well known that
COVID-19 presents with a complex pathophysiological dynamic traversing the stages of early
infection, pulmonary manifestation, thrombo-inflammation and hyperinflammation [30–37].
Thus it seems not to be surprising that pulmonary blood flow is subject to fluctuations during
course of disease.
We systematically evaluated a cohort of 27 patients with RT-PCR proven COVID-19 pneu-
monia being treated in a tertiary care university hospital. All except one patient required inten-
sive care, 89% were mechanically ventilated. Thus our cohort represents the subset of
advanced and severe disease stage. We focused on the subgroup of severely diseased patients
in order a) to establish a homogeneous study group in terms of stage of lung injury and b) to
investigate a study group at risk with a strong need for further pathophysiological insight.
DECT demonstrated a wide range of perfusion characteristics of pulmonary opacifications
(both GGO and consolidation) with some being hypo- and others being hyperperfused.
Increased iodine uptake was associated with an increase of intralesional vessel diameter. This
feature has been described as typical for COVID-19 pneumonia [16–18]. Expectedly, opacifi-
cations downstream of pulmonary embolism demonstrated decreased iodine uptake.
Our results raise new aspects regarding the nature of lung injury caused by SARS-CoV-2 in
the advanced stage. On one hand, we saw opacifications that were hypoperfused as compared
to normally aerated lung. This finding is in line with the investigations of Lang et al. and Si-
Mohamed et al. and supports the hypothesis of dead-space ventilation as one cause of impaired
gas exchange [22, 25, 26].
On the other hand, we were able to demonstrate that a considerable fraction of opacifica-
tions is hyperperfused despite being diminished or non-ventilated. This finding suggests the
presence of a functional intrapulmonary right-to-left shunt. Estimation of the amount of
Fig 5. Iodine uptake (mg/mL) of normally aerated lung (estimated mean: 1.22; 95%-CI: 0.95–1.49), areas of
ground-glass opacification (estimated mean: 1.77; 95%-CI: 1.52–2.02), and consolidation (estimated mean: 1.82;
95%-CI: 1.56–2.08) without upstream pulmonary embolism.
https://doi.org/10.1371/journal.pone.0252478.g005
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hyperperfused lung tissue on CTs performed without dual-energy technique might be possible
by evaluation of the prevalence of vessel enlargement the presence of which correlated with
hyperperfusion. An in-depth pathophysiological discussion is beyond the scope of the article.
However, a direct effect of SARS-CoV-2 on the vascular autoregulation has been discussed
and attributed to the virus’ affinity to the ACE-2 receptor [38]. Thus, hyperaemia is possibly
mediated by vasodilation or failed hypoxic vasoconstriction [2]. Also, neo-angiogenesis was
described in COVID-19 pneumonia in a recently published autopsy series [13]. Our findings
might help to tailor the therapeutic management to the individual patient´s situation. Patients
with predominant hypoperfusion / deadspace ventilation and/or pulmonary embolism will
likely benefit from inhalative vasodilators (e.g. NO or prostacycline) which on the other hand
might be deleterious for patients with mainly hyperperfused opacifications and vessel
enlargement.
Limitations of our study are as follows: The sample size was rather small and the study
design was retrospective. Thus our results have to be confirmed in future studies. More impor-
tantly, the conclusions drawn for clinical management have to be carefully evaluated. Selection
of measurement areas for perfusion analysis was subjective and the ROIs represented a sample
of the entire volume of opacifications. However, placing of ROIs were guided by the colour-
coded iodine map enabling registration of the entire range PBV. Artificial intelligence-
enhanced computing algorithms could enable the registration of iodine uptake over the entire
Fig 6. Iodine uptake (mg/mL) of normally aerated lung (estimated mean: 1.22; 95%-CI: 0.95–1.49), areas of
ground-glass opacification without and with vessel enlargement (estimated mean: 1.15; 95%-CI: 0.79–1.15; and
2.01; 95%-CI: 1.74–2.28, respectively), and areas of consolidation without and with vessel enlargement (estimated
mean: 1.21; 95%-CI: 0.90–1.53; and 2.28; 95%-CI: 1.98–2.57, respectively).
https://doi.org/10.1371/journal.pone.0252478.g006
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extent of opacifications. Such a software, however, was not available at our institution. The
DECTs were acquired with different protocols regarding iodine delivery rate. This was due the
fact that DECTs from clinical routine were analyzed. However, results were presented and ana-
lyzed with regard to the relative difference of iodine uptake in opacifications compared to nor-
mally aerated lung. This way an intraindividual normalization was established.
In summary, we were able to demonstrate that opacifications in patients with severe
COVID-19 pneumonia can be both hypoperfused and hyperperfused. Indeed, the mean iodine
uptake within pulmonary opacifications in our cohort was higher than that in normally aer-
ated lung. Thus, impaired gas exchange might be caused by a combination of dead-space venti-
lation and functional intrapulmonary right-to-left shunt. Of note, intralesional vessel
enlargement correlated with iodine uptake. Further research including correlation of perfusion
imaging with ventilation parameters, minimal-invasive shunt assessment via right heart cathe-
terization and histopathology is mandatory for a better understanding of the pathophysiology
of COVID-19 pneumonia.
Conclusion
Assessment of lung perfusion with DECT in advanced COVID-19 pneumonia revealed opaci-
fications to be both hypo- and hyperperfused. Thus, a combination of dead-space ventilation
and functional intrapulmonary right-to-left shunt might contribute to impairment of gas
exchange. Applying DECT to determine which pathophysiology is predominant might help to
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